Internal Server Error

Roche - About the company

Roche is a public company based in Basel (Switzerland), founded in 1896 by Fritz Hoffmann La Roche. It operates as a Developer of pharmaceuticals and diagnostics kits. Roche has raised an undisclosed amount in funding. The company has 2163 active competitors, including 140 funded and 235 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.

Company Details

Developer of pharmaceuticals and diagnostics kits for multiple diseases. It manufactures diagnostic equipment and reagents for research and medical diagnostic applications. In 2022, the company recorded annual revenues of $66.26B and a net profit of $13.01B
Social
XFacebook
Email ID
*****@roche.com
Phone Number
+41 **********
Registered Address
Little Falls, New Jersey
Key Metrics
Founded Year
1896
Location
Basel, Switzerland
Stage
Public
Latest Funding Round
Ranked
Annual Revenue
£10M - £50M as on Jul 31, 2022
Employee Count
105,566 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public

Roche's IPO details

Roche got listed on Dec 05, 2002.
Click here to take a look at Roche's IPO in detail
Sign up to download Roche's company profile

Roche's funding and investors

Roche has raised funding over 18 rounds. Its first funding round was on May 01, 2004. Its latest funding round was a Post IPO round on May 21, 2023 for $*****. 1 investor participated in its latest round. Roche has 13 institutional investors.

Here is the list of recent funding rounds of Roche:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 21, 2023
4064132
Post IPO
4960646
1771207
9666681
3590874
Jun 01, 2022
2071673
Grant (prize money)
6900740
5124186
2552980
Aug 05, 2021
2359039
Post IPO
9645485
8951512
2044030
lockAccess funding benchmarks and valuations. Sign up today!

Roche's founders and board of directors

Founder? Claim Profile
The founders of Roche is Fritz Hoffmann La Roche.
Here are the details of Roche's key team members:

Roche's Board of Directors

Roche's board has 4 active members. Alan Hippe, Claudia Böckstiegel and Thomas Schinecker are part of team and Urs Lauffer is independent board member.
Here is the list of Roche's board of directors:
Name
Type
Representing
Status
Duration
vscfprf
Team
-
Current
4y 6m
{ymuggu
Team
-
Current
8y 5m
gxhxfel
Team
-
Current
5y 4m
Independent board member
-
Current
-

Roche's employee count trend

Roche has 105,566 employees as of May 26. Here is Roche's employee count trend over the years:
Employee count trend for Roche
lockUncover Roche's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Roche's Competitors and alternates

Top competitors of Roche include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Roche, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for AbbVie
AbbVie
2012, Chicago (United States), Public
Research-based biopharmaceutical company
$14.7B
81/100
2nd
Logo for Amgen
Amgen
1980, Thousand Oaks (United States), Public
Developer of pharmaceutical products for treating multiple diseases
-
81/100
3rd
Logo for Gilead
Gilead
1987, Foster City (United States), Acquired
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
-
80/100
4th
Logo for Lilly
Lilly
1876, Indianapolis (United States), Public
Developer of traditional pharmaceutical medicines
-
75/100
5th
Logo for Johnson & Johnson
Johnson & Johnson
1886, New Brunswick (United States), Public
Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products
-
74/100
6th
Logo for AstraZeneca
AstraZeneca
1999, Cambridge (United Kingdom), Public
Developer of pharmaceutical medicines for oncology and various chronic diseases
-
73/100
7th
Logo for Novartis
Novartis
1996, Basel (Switzerland), Acquired
R&D focused on manufacturing of drugs for multiple therapeutic areas
-
71/100
8th
Logo for Roivant Sciences
Roivant Sciences
2014, New York City (United States), Public
Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases
$1.3B
70/100
9th
Logo for Roche
Roche
1896, Basel (Switzerland), Public
Developer of pharmaceuticals and diagnostics kits
-
70/100
10th
Logo for Genentech
Genentech
1976, San Francisco (United States), Acquired
R&D company focused on manufacturing drugs for multiple therapeutic areas
$72.5M
69/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Roche's competitors? Click here to see the top ones

Roche's Investments and acquisitions

Roche has made 44 investments in companies including Mironid and Mission Therapeutics. Roche has also acquired 49 companies including 89bio and Poseida Therapeutics.
Here is the list of investments & acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Aug 05, 2026
Investments
2015
Glasgow (United Kingdom)
Oct 15, 2025
Investments
2011
Cambridge (United Kingdom)
Sep 17, 2025
Acquisition
2018
San Francisco (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all investments and acquisitions by Roche

News related to Roche

lockFilter this list
Media has covered Roche for a total of 227 events in the last 1 year, 82 of them have been about company updates and 29 about partnerships.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Roche

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford